12 news items
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
INCY
JAZZ
MIRA
23 Jul 24
of telomere targeting as a therapeutic strategy, and we share in the enthusiasm for the FDA approval of imetelstat for rare blood cancers originating
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
CRWD
MIRA
RYAAY
22 Jul 24
. (NYSE:SVV) was down, falling 15% to $9.86 after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $21 to $12
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
APLD
ATPC
AVAH
22 Jul 24
to Neutral and lowered its price target from $21 to $12.
Fitell Corporation
Dow Edges Lower; Verizon Shares Fall After Q2 Results
CRWD
MIRA
RYAAY
22 Jul 24
. (NYSE:SVV) was down, falling 12% to $10.23 after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA
22 Jul 24
into target tissues would allow for lower doses of Ketamir-2 to achieve therapeutic effects.Preclinical Results and Ongoing
9njm85bncfswd8z47unfkvnotjiff93a8s775p8031y2onx85zv4ngsjkfjy
AEON
AES
AGRI
15 Jul 24
and announced a price target of $30.
BitFuFu Inc
snr9 3ig728sb6i2k69vmo0dtpyw0sjbigoof4i84lse
MIRA
15 Jul 24
and prolonged therapeutic benefits, making it a more promising candidate for its target indications.
In studies exploring its potential
re9h t11t6
MIRA
15 Jul 24
-55 could provide more consistent and prolonged therapeutic benefits, making it a more promising candidate for its target indications.In studies
vz17entf0e3ichdm961ssgkdrbpoez
MIRA
10 Jun 24
pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. MIRA holds
wuc1bkgg1q 5bxf6noed2u3tpj
MIRA
29 May 24
pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. MIRA holds the exclusive
g0nbyy2lsn3a3dhvhgeh973xbt3hcnrns5vy4t57r86wjbech
MIRA
21 May 24
with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. MIRA holds the exclusive U.S., Canadian
p9mt7j3qxvra6ghanj4eh h18lbma5opro0i5cb5jjwnr6ys
MIRA
20 May 24
antidepressant effects and improved safety profile. Unlike traditional SSRIs and benzodiazepines, Ketamir-2 targets NMDA receptors in the brain
- Prev
- 1
- Next